Hematology
From the Journals
Patients with CLL have significantly reduced response to COVID-19 vaccine
Less than half of CLL patients had an antibody-mediated response to the Pfizer vaccine in a study.
From the Journals
Health costs over 25 times higher for hemophilia B patients than controls
Conference Coverage
Pediatric cancer survivors at risk for opioid misuse
From the Journals
High variability found in studies assessing hemophilia-related pain
From the Journals
AHA guidance on blood clots linked to COVID-19 vaccine
Commentary
Commentary: Functional assessment developed for older adults with sickle cell disease
From the Journals
Predicting outcomes in therapy-related AML
News
How some COVID-19 vaccines could cause rare blood clots
Six cases of a rare but serious event in patients who got the J&J vaccine are being reviewed.
From the Journals
COVID-19 vaccine failure in patients with blood cancers
From the Journals
Palliative care helpful but underutilized for blood cancer patients
Feature
VEXAS: A novel rheumatologic, hematologic syndrome that’s making waves